{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T23:54:12Z","timestamp":1777852452632,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Development Program of Jinan Municipal Health Commission","award":["2023-2-140"],"award-info":[{"award-number":["2023-2-140"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"DOI":"10.1186\/s13052-026-02239-0","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:45:55Z","timestamp":1774086355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective study: clinical analysis of Kawasaki disease complicated with macrophage activation syndrome"],"prefix":"10.1186","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4825-726X","authenticated-orcid":false,"given":"Wenhui","family":"Bie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqiang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingxia","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiru","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"issue":"17","key":"2239_CR1","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135(17):e927\u201399. https:\/\/doi.org\/10.1161\/CIR.0000000000000484.","journal-title":"Circulation"},{"key":"2239_CR2","doi-asserted-by":"publisher","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, et al. Ann Rheum Dis. 2016;75(3):481\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208982. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.","DOI":"10.1136\/annrheumdis-2015-208982"},{"issue":"5","key":"2239_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3345\/kjp.2018.61.5.167","volume":"61","author":"JE Choi","year":"2018","unstructured":"Choi JE, Kwak Y, Huh JW, et al. Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide. Korean J Pediatr. 2018;61(5):167\u201373. https:\/\/doi.org\/10.3345\/kjp.2018.61.5.167.","journal-title":"Korean J Pediatr"},{"issue":"6","key":"2239_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/MPH.0000000000000872","volume":"39","author":"S Garc\u00eda-Pav\u00f3n","year":"2017","unstructured":"Garc\u00eda-Pav\u00f3n S, Yamazaki-Nakashimada MA, B\u00e1ez M, et al. Kawasaki Disease Complicated With Macrophage Activation Syndrome: A Systematic Review. J Pediatr Hematol Oncol. 2017;39(6):445\u201351. https:\/\/doi.org\/10.1097\/MPH.0000000000000872.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"2239_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.semarthrit.2014.07.007","volume":"44","author":"W Wang","year":"2015","unstructured":"Wang W, Gong F, Zhu W, et al. Macrophage activation syndrome in Kawasaki disease: more common than we thought? Semin Arthritis Rheum. 2015;44(4):405\u201310. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.07.007.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"2239_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/MPH.0b013e3181dccbf4","volume":"32","author":"GA Latino","year":"2010","unstructured":"Latino GA, Manlhiot C, Yeung RS, et al. Macrophage activation syndrome in the acute phase of Kawasaki disease. J Pediatr Hematol Oncol. 2010;32(7):527\u201331. https:\/\/doi.org\/10.1097\/MPH.0b013e3181dccbf4.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2239_CR7","doi-asserted-by":"crossref","unstructured":"Ha S, Seo GH, Kim KY et al. Epidemiologic Study on Kawasaki Disease in Korea, 2007\u20132014: Based on Health Insurance Review & Assessment Service Claims. J Korean Med Sci, 2016, 31(9): 1445-9.doi: 110.3346\/jkms.2016.31.9.1445.","DOI":"10.3346\/jkms.2016.31.9.1445"},{"issue":"2","key":"2239_CR8","first-page":"343","volume":"35","author":"EM Behrens","year":"2008","unstructured":"Behrens EM, Beukelman T, Gallo L, et al. Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol. 2008;35(2):343\u20138. PMID:18085728.","journal-title":"J Rheumatol"},{"issue":"7","key":"2239_CR9","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1093\/rheumatology\/keaa715","volume":"60","author":"RK Pilania","year":"2021","unstructured":"Pilania RK, Jindal AK, Johnson N, et al. Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India. Rheumatology (Oxford). 2021;60(7):3413\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/keaa715.","journal-title":"Rheumatology (Oxford)"},{"key":"2239_CR10","doi-asserted-by":"publisher","unstructured":"Wen Y. Chen Jing,Liu Fan,Clinical features of Kawasaki disease complicated by macrophage activation syndrome:an analysis of 27 cases.Chinese Journal of Contemporary Pediatrics,2023, 25(6): 572\u2013578.https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2302015","DOI":"10.7499\/j.issn.1008-8830.2302015"},{"issue":"6","key":"2239_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/INF.0b013e3181cf8705","volume":"29","author":"RC Holman","year":"2010","unstructured":"Holman RC, Belay ED, Christensen KY, et al. Hospitalizations for Kawasaki syndrome among children in the United States, 1997\u20132007. Pediatr Infect Dis J. 2010;29(6):483\u20138. https:\/\/doi.org\/10.1097\/INF.0b013e3181cf8705.","journal-title":"Pediatr Infect Dis J"},{"key":"2239_CR12","doi-asserted-by":"publisher","unstructured":"Jin P, Luo Y, Liu X et al. Kawasaki Disease Complicated With Macrophage Activation Syndrome: Case Reports and Literature Review. Front Pediatr, 2019, 7: 423.https:\/\/doi.org\/10.3389\/fped.2019.00423. eCollection 2019.","DOI":"10.3389\/fped.2019.00423"},{"issue":"1","key":"2239_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12519-019-00256-0","volume":"16","author":"LX Zou","year":"2020","unstructured":"Zou LX, Zhu Y, Sun L, et al. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China. World J Pediatr. 2020;16(1):89\u201398. https:\/\/doi.org\/10.1007\/s12519-019-00256-0.","journal-title":"World J Pediatr"},{"issue":"5","key":"2239_CR14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/adc.85.5.421","volume":"85","author":"S Sawhney","year":"2001","unstructured":"Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001;85(5):421\u20136. https:\/\/doi.org\/10.1136\/adc.85.5.421.","journal-title":"Arch Dis Child"},{"issue":"11","key":"2239_CR15","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","volume":"66","author":"F Minoia","year":"2014","unstructured":"Minoia F, Dav\u00ec S, Horne A, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol. 2014;66(11):3160\u20139. https:\/\/doi.org\/10.1002\/art.38802.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"2239_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13148-018-0557-1","volume":"10","author":"LH Huang","year":"2018","unstructured":"Huang LH, Kuo HC, Pan CT, et al. Multiomics analyses identified epigenetic modulation of the S100A gene family in Kawasaki disease and their significant involvement in neutrophil transendothelial migration[J]. Clin Epigenetics. 2018;10(1):135. https:\/\/doi.org\/10.1186\/s13148-018-0557-1.","journal-title":"Clin Epigenetics"},{"issue":"11","key":"2239_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.19538\/j.ek2020110605","volume":"35","author":"Chinese Physician Association Pediatric Branch Rheumatology Immunology Group","year":"2020","unstructured":"Chinese Physician Association Pediatric Branch Rheumatology Immunology Group. China Children\u2019s Immunity and Health Alliance,Editorial Board of Chinese Journal of Practical Pediatrics. Expert consensus on diagnosis and treatment of macrophage activation syndrome associated with rheumatic diseases in children part V: Kawasaki disease. Chin J Practical Pediatr. 2020;35(11):841\u20135. https:\/\/doi.org\/10.19538\/j.ek2020110605.","journal-title":"Chin J Practical Pediatr"},{"key":"2239_CR18","doi-asserted-by":"publisher","unstructured":"Wang S, Gengying L. Du Zhongdong.Review of Kawasaki disease complicated with macrophage activation syndrome. Chin J Pediatr 2020,58(11):953\u20136.https:\/\/doi.org\/10.3760\/cma.j.cn112140-20200407-00354","DOI":"10.3760\/cma.j.cn112140-20200407-00354"},{"issue":"2","key":"2239_CR19","first-page":"148","volume":"51","author":"D Mukherjee","year":"2014","unstructured":"Mukherjee D, Pal P, Kundu R, et al. Macrophage activation syndrome in Kawasaki disease. Indian Pediatr. 2014;51(2):148\u20139. PMID:24632699.","journal-title":"Indian Pediatr"},{"key":"2239_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/OARRR.S151013","volume":"10","author":"B Lerkvaleekul","year":"2018","unstructured":"Lerkvaleekul B, Vilaiyuk S. Macrophage activation syndrome: early diagnosis is key. Open Access Rheumatol. 2018;10:117\u201328. https:\/\/doi.org\/10.2147\/OARRR.S151013. eCollection 2018.","journal-title":"Open Access Rheumatol"},{"key":"2239_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ijcard.2016.03.017","volume":"214","author":"T Kibata","year":"2016","unstructured":"Kibata T, Suzuki Y, Hasegawa S, et al. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin. Int J Cardiol. 2016;214:209\u201315. https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.017.","journal-title":"Int J Cardiol"},{"issue":"1","key":"2239_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5114\/aoms\/144293","volume":"18","author":"Z Qiu","year":"2022","unstructured":"Qiu Z, Liu HH, Fan GZ, et al. The clinical implications of serum ferritin in Kawasaki disease: a helpful biomarker for evaluating therapeutic responsiveness, coronary artery involvement and the tendency of macrophage activation syndrome. Arch Med Sci. 2022;18(1):267\u201374. https:\/\/doi.org\/10.5114\/aoms\/144293.","journal-title":"Arch Med Sci"},{"issue":"4","key":"2239_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/children8040269","volume":"8","author":"DE Roh","year":"2021","unstructured":"Roh DE, Kwon JE, Choi HJ, et al. Importance of Serum Ferritin Level for Early Diagnosis and Differentiation in Patients with Kawasaki Disease with Macrophage Activation Syndrome. Child (Basel). 2021;8(4):269. https:\/\/doi.org\/10.3390\/children8040269.","journal-title":"Child (Basel)"},{"issue":"4","key":"2239_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.5045\/br.2013.48.4.254","volume":"48","author":"HR Kang","year":"2013","unstructured":"Kang HR, Kwon YH, Yoo ES, et al. Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease. Blood Res. 2013;48(4):254\u20137. https:\/\/doi.org\/10.5045\/br.2013.48.4.254.","journal-title":"Blood Res"},{"issue":"1","key":"2239_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1253\/circj.CJ-17-0433","volume":"82","author":"R Fukazawa","year":"2017","unstructured":"Fukazawa R, Kobayashi T, Mikami M, et al. Nationwide Survey of Patients With Giant Coronary Aneurysm Secondary to Kawasaki Disease 1999\u20132010 in Japan. Circ J. 2017;82(1):239\u201346. https:\/\/doi.org\/10.1253\/circj.CJ-17-0433.","journal-title":"Circ J"},{"issue":"9","key":"2239_CR26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1586\/1744666X.2015.1058159","volume":"11","author":"RQ Cron","year":"2015","unstructured":"Cron RQ, Davi S, Minoia F, et al. Clinical features and correct diagnosis of macrophage activation syndrome. Expert Rev Clin Immunol. 2015;11(9):1043\u201353. https:\/\/doi.org\/10.1586\/1744666X.2015.1058159.","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"2239_CR27","doi-asserted-by":"publisher","first-page":"e229708","DOI":"10.1136\/bcr-2019-229708","volume":"12","author":"M Lind-Holst","year":"2019","unstructured":"Lind-Holst M, Hartling UB, Christensen AE. High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant. BMJ Case Rep. 2019;12(8):e229708. https:\/\/doi.org\/10.1136\/bcr-2019-229708.","journal-title":"BMJ Case Rep"},{"key":"2239_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","volume":"66","author":"GS Schulert","year":"2015","unstructured":"Schulert GS, Grom AA. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies. Annu Rev Med. 2015;66:145\u201359. https:\/\/doi.org\/10.1146\/annurev-med-061813-012806.","journal-title":"Annu Rev Med"},{"key":"2239_CR29","doi-asserted-by":"publisher","unstructured":"Shanxi Provincial Kawasaki Disease Diagnosis and Treatment Center\/Shanxi Provincial People\u2019s Hospital Children\u2019s Hospital. National Center for Children\u2019s Medicine\/Beijing Children\u2019s Hospital, Capital Medical University, Shanghai Children\u2019s Hospital, Shanghai Jiao Tong University School of Medicine, Evidence-based guidelines for the diagnosis and treatment of Kawasaki disease in children in China(2023).Chinese Journal of ContemporaryPediatrics,2023,25(12):1198\u20131210.https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2309038","DOI":"10.7499\/j.issn.1008-8830.2309038"},{"issue":"10","key":"2239_CR30","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/1756-185X.13915","volume":"23","author":"P Pal","year":"2020","unstructured":"Pal P, Bathia J, Giri PP, et al. Macrophage activation syndrome in pediatrics: 10 years data from an Indian center. Int J Rheum Dis. 2020;23(10):1412\u20136. https:\/\/doi.org\/10.1111\/1756-185X.13915.","journal-title":"Int J Rheum Dis"},{"key":"2239_CR31","doi-asserted-by":"publisher","unstructured":"Xu Li H, Shengnan Z et al. Yu,. Clinical study of juvenile rheumatic disease-associated macrophage activation syndrome: A retrospective study from a single center.Chinese Journal of Practical Pediatrics, 2021, 36(4): 285\u2013291.https:\/\/doi.org\/10.19538\/j.ek2021040610","DOI":"10.19538\/j.ek2021040610"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-026-02239-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02239-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02239-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:36:29Z","timestamp":1777502189000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13052-026-02239-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2239"],"URL":"https:\/\/doi.org\/10.1186\/s13052-026-02239-0","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principlesof the declaration of Helsinki, and approved by the Medical Ethics Committees of the Jinan Children\u2019s Hospital (SDFE-IRB\/P-2023032).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"I declare that there are no conflicts of interest in relation to the manuscript titled \u201cRetrospective study: Clinical analysis of Kawasaki disease complicated with macrophage activation syndrome\u201d submitted to journal Italian Journal of Pediatrics. All participants were informed and gave their consent for the publication of the article. This study does not involve human participants or animal experiments, so no informed consent is required. This study was approved by the Research Ethics Committees of the Jinan Children\u2019s Hospital (SDFE\u2014IRB\/P\u20142023032). I confirm that the results and interpretations reported in the manuscript are original and have not been plagiarized. The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"71"}}